Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled study

P. Joly, I. Tejedor, F. Tétart, Hélène Collas Cailleux, Alice Barrel, Paul Arnaud De Preville, Nathalie Mion-Mouton, G. Gabison, Sophie Baricault, Catherine Girardin Tordeur, Martin Xavier Dore, Bernard Rossi, Catherine Bourseau‐Quetier, Mélanie Chamaillard, Sandra Ly, O. Chosidow, Marie-Aleth Richard-Lallemand, Jean-Claude Rzeznik, Jean‐Michel Amici, G Lair, Sylvie Bechu, Jacques Bénichou, Caroline Thill, M. Beylot‐Barry